Key result
Disodium cromoglycate reduces neointimal hyperplasia after arterial injury in mice.
Why the study?
The study investigated the role of mast cells in post-endothelial injury inflammation and evaluated whether mast cell stabilization could serve as a target for therapy.
Does disodium cromoglycate (DSCG) reduce neointimal hyperplasia in mice following arterial injury?
Population
Transplanted mice and wild-type mice undergoing arterial injury
Comparison
Disodium cromoglycate administered immediately following arterial injury
Design
Preclinical animal study
Authors
Loading...
Hypothesis-generating for mast cell stabilization to prevent restenosis; requires clinical validation before any practice change.
Does disodium cromoglycate (DSCG) reduce neointimal hyperplasia in mice following arterial injury?
Mast cell stabilization with disodium cromoglycate reduces neointimal hyperplasia after arterial injury in mice, suggesting a potential therapeutic target to prevent restenosis after revascularization procedures.
Harper et al. (2023) studied Acute artery injury and neointimal hyperplasia. Disodium cromoglycate (DSCG) was evaluated on Neointimal hyperplasia. Administration of the mast cell stabilizing drug disodium cromoglycate immediately following arterial injury reduced neointimal hyperplasia in wild-type mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: